Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Confirmation Biases

Confirmation Biases

The confirmation bias is the tendency to focus on information that confirms our existing beliefs and ignore information that is inconsistent with our expectations. For example, if you think that your professor is not very nice, you notice all of the instances of rude behavior exhibited by the professor while ignoring the countless pleasant interactions he is involved in on a daily basis. Have you ever fallen prey to the confirmation bias, either as the source or target of such bias?

Beck's Cognitive Therapy

Beck's Cognitive Therapy

Cognitive therapy is a psychological approach designed to address distortions in thinking, which can lead to negative emotions and unrealistic beliefs. These cognitive distortions often influence how individuals interpret and respond to situations, exacerbating emotional distress. Below are some prevalent cognitive distortions, their characteristics, and examples of how they manifest in thought processes.
Arbitrary Inference
Arbitrary inference involves making conclusions without sufficient...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Efficacy of post-transplant brentuximab vedotin maintenance by pre-transplant disease status in relapsed/refractory classic Hodgkin lymphoma.

Blood cancer journal·2026

Same author

Nivolumab+AVD in Advanced-Stage Classic Hodgkin's Lymphoma.

The New England journal of medicine·2024

Same author

Randomized study of induction with bendamustine-rituximab ± bortezomib and maintenance with rituximab ± lenalidomide for MCL.

Blood·2024

Same author

Impact of imaging frequency on progression-free survival in Alliance trials enrolling patients with follicular lymphoma.

Blood advances·2024

Same author

Overall survival of patients with cHL who progress after autologous stem cell transplant: results in the novel agent era.

Blood advances·2023

Same author

A phase II study of interrupted and continuous dose lenalidomide in relapsed/refractory Hodgkin lymphoma.

Haematologica·2023

Search research articles

Related Experiment Video

Updated: Apr 16, 2026

Combining Reflectance Confocal Microscopy with Optical Coherence Tomography for Noninvasive Diagnosis of Skin Cancers via Image Acquisition

Combining Reflectance Confocal Microscopy with Optical Coherence Tomography for Noninvasive Diagnosis of Skin Cancers via Image Acquisition

Published on: August 18, 2022

CD30: seeing is not always believing.

Kristie A Blum¹

¹THE OHIO STATE UNIVERSITY COMPREHENSIVE CANCER CENTER.

|February 28, 2015

Summary

This summary is machine-generated.

Brentuximab vedotin shows surprising effectiveness in treating B-cell non-Hodgkin lymphoma (NHL). This finding expands the known applications of this drug beyond Hodgkin lymphoma (HL) and anaplastic large-cell lymphoma (ALCL).

More Related Videos

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

Quantitative Imaging of Lineage-specific Toll-like Receptor-mediated Signaling in Monocytes and Dendritic Cells from Small Samples of Human Blood

Quantitative Imaging of Lineage-specific Toll-like Receptor-mediated Signaling in Monocytes and Dendritic Cells from Small Samples of Human Blood

Published on: April 16, 2012

Related Experiment Videos

Last Updated: Apr 16, 2026

Combining Reflectance Confocal Microscopy with Optical Coherence Tomography for Noninvasive Diagnosis of Skin Cancers via Image Acquisition

Combining Reflectance Confocal Microscopy with Optical Coherence Tomography for Noninvasive Diagnosis of Skin Cancers via Image Acquisition

Published on: August 18, 2022

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

Quantitative Imaging of Lineage-specific Toll-like Receptor-mediated Signaling in Monocytes and Dendritic Cells from Small Samples of Human Blood

Quantitative Imaging of Lineage-specific Toll-like Receptor-mediated Signaling in Monocytes and Dendritic Cells from Small Samples of Human Blood

Published on: April 16, 2012

Area of Science:

Oncology
Hematology
Pharmacology

Background:

Brentuximab vedotin is an established treatment for Hodgkin lymphoma (HL) and anaplastic large-cell lymphoma (ALCL).
Its efficacy in B-cell non-Hodgkin lymphoma (NHL) has been less explored.

Purpose of the Study:

To investigate the activity of brentuximab vedotin in patients with B-cell non-Hodgkin lymphoma (NHL).

Main Methods:

The study by Jacobsen and colleagues evaluated brentuximab vedotin in NHL patients.
Specific patient cohorts and treatment protocols were assessed.

Main Results:

Brentuximab vedotin demonstrated surprising activity in patients with B-cell non-Hodgkin lymphoma (NHL).
These results suggest a broader potential application for the drug.

Conclusions:

Brentuximab vedotin exhibits significant activity in B-cell non-Hodgkin lymphoma (NHL).
This expands the therapeutic landscape for brentuximab vedotin beyond its current indications.